✦ LIBER ✦

Optimisation of the tumour response threshold in patients treated with everolimus for metastatic renal cell carcinoma: Analysis of response and progression-free survival in the RECORD-1 study

✍ Scribed by Stéphane Oudard; Rokhaya Thiam; Laure S. Fournier; Jacques Medioni; Michele Lamuraglia; Florian Scotte; Elizabeth Fabre; Dennis Kim; Euloge Kpamegan; Ashok Panneerselvam; Charles A. Cuenod

Book ID: 116431015
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 422 KB
Volume: 48
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2012.01.027

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The association of pre-treatment neutrop

The association of pre-treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma

✍ Daniel Keizman; Maya Ish-Shalom; Peng Huang; Mario A. Eisenberger; Roberto Pili; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 310 KB

Efficacy and Safety of Everolimus in Eld

Efficacy and Safety of Everolimus in Elderly Patients With Metastatic Renal Cell Carcinoma: An Exploratory Analysis of the Outcomes of Elderly Patients in the RECORD-1 Trial

✍ Camillo Porta; Emiliano Calvo; Miguel A. Climent; Ulka Vaishampayan; Susanne Osa 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 424 KB

Association of percentage of tumour burd

Association of percentage of tumour burden removed with debulking nephrectomy and progression-free survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy

✍ Juan Barbastefano; Jorge A. Garcia; Paul Elson; Laura S. Wood; Brian R. Lane; Ro 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB

Optimisation of the size variation thres

Optimisation of the size variation threshold for imaging evaluation of response in patients with platinum-refractory advanced transitional cell carcinoma of the urothelium treated with vinflunine

✍ Katherine M. Krajewski; Ronan Fougeray; Joaquim Bellmunt; Francesc Pons; Fabio A 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 548 KB

Everolimus in metastatic renal cell carc

Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study

✍ E. Calvo; B. Escudier; R.J. Motzer; S. Oudard; T.E. Hutson; C. Porta; S. Bracard 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 262 KB

High-dose interleukin-2 for the treatmen

High-dose interleukin-2 for the treatment of metastatic renal cell carcinoma : A retrospective analysis of response and survival in patients treated in the surgery branch at the National Cancer Institute between 1986 and 2006

✍ Jacob A. Klapper; Stephanie G. Downey; Franz O. Smith; James C. Yang; Marybeth S 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 1 views